ADI
76
3
HBAN
82
-5
AZO
48
5
DAL
70
-4
DRI
60
-3
DG
68
-6
JBHT
62
-3
MU
76
-3
ALL
63
2
LEG
54
-3
APH
58
3
RHI
37
-2
JNJ
51
-3
ADP
53
-2
O
31
-2
FE
52
2
KSS
56
-2
CMCSA
52
2
NOV
53
-2
FSLR
72
-6
ADI
76
3
HBAN
82
-5
AZO
48
5
DAL
70
-4
DRI
60
-3
DG
68
-6
JBHT
62
-3
MU
76
-3
ALL
63
2
LEG
54
-3
APH
58
3
RHI
37
-2
JNJ
51
-3
ADP
53
-2
O
31
-2
FE
52
2
KSS
56
-2
CMCSA
52
2
NOV
53
-2
FSLR
72
-6
Financhill
Back

Arcus Biosciences, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
24

RCUS
Arcus Biosciences, Inc.

Last Price:
$22.69
Seasonality Move:
-9.85%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$71.39
Seasonality Move:
-34.19%
Sell
24
Arcus Biosciences, Inc. (RCUS) is a Sell

Is Arcus Biosciences, Inc. a Buy, Sell or Hold?

  • The current Arcus Biosciences, Inc. [RCUS] share price is $22.71. The Score for RCUS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • RCUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RCUS Stock Price Chart

What is Arcus Biosciences, Inc.'s stock price today?

  • The Arcus Biosciences, Inc. share price today is $22.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.57 Buy
Relative Strength Index (14 RSI): 50.45 Buy
Chaikin Money Flow: -463585 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.69 - 25.51) Sell
Bollinger Bands (100): (11.08 - 21.76) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

RCUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.23 Buy
20-day SMA: 24.15 Sell
50-day SMA: 21.18 Buy
200-day SMA: 12.59 Buy
8-day EMA: 16.13 Buy
20-day EMA: 8.85 Buy
50-day EMA: 4.07 Buy
200-day EMA: 1.09 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Arcus Biosciences, Inc. Earnings Growth & RCUS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.37 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Arcus Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):